Costs and Benefits of Methadone Treatment in DATOS- Part 1: Discharged versus Continuing Patients

Journal of Maintenance in the Addictions

Volumn 2, Issue 1-2, 2002, Pages 129-149

  Rounds Bryant, Jennifer L ^a   Flynn, Patrick M ^a   Porto, James V ^b   Kristiansen, Patricia L ^c  

^a TEXAS CHRISTIAN UNIVERSITY   (United States)

^b IL   (United States)

^c NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

Cost benefits; Discharges; Maintenance; Methadone treatment

Indexed keywords

EID: 85010521493     PISSN: 10911332     EISSN: 15407624     Source Type: Journal    
DOI: 10.1300/J126v02n01_08     Document Type: Article

References (38)

1. Anglin, M.D., Speckart, G.R., Booth, M.W., & Ryan, T.M. (1989). Consequences and costs of shutting off methadone. Addictive Behavior, 14(3), 307-326.
2. Avants, S.K., Margolin, A., Sindelar, J.L., Rounsaville, B.J., Schottenfeld, R., Stine, S., Cooney, N.L., Rosenheck, R.A., Li, S.H., & Kosten, T.R. (1999). Day treatment versus enhanced standard methadone service for opioid-dependent patients: A Comparison of clinical efficacy and cost. American Journal of Psychiatry, 156(1), 27-33.
3. Chatham, L.R., Hiller, M.L., Rowan-Szal, G.A., Joe, G.W., & Simpson, D.D. (1999). Gender differences at admission and follow-up in a sample of methadone maintenance clients. Substance Use and Misuse, 34(8), 1137-1165.
4. Babor, T.F., Stephens, R.S., & Marlatt, G.A. (1987). Verbal report methods of clinical research on alcoholism: Response bias and its minimization. Journal of Studies on Alcohol, 48, 410-424.
5. Ball, J.C., Lange, W.R., Myers, C.P., & Friedman, S.R. (1988). Reducing the risk of aids through methadone maintenance treatment. Journal of Health and Social Behavior, 29, 214-226.
6. Ball, J.C., & Ross, A. (1991). The effectiveness of methadone maintenance treatment: Patients, programs, services, and outcomes. New York: Springer-Verlag.
7. Bonito, A.J., Nurco, D.N., & Shaffer, J.W. (1976). The veridicality of addicts’ self-reports in social research. The International Journal of the Addictions, 11, 719-724.
8. Broome, K.M., Joe, G.W., & Simpson, D.D. (1999). HIV risk reduction in outpatient drug abuse treatment: Individual and geographic differences. AIDS Education and Prevention, 11(4), 293-306.
9. Chatham, L.R., Hiller, M.L., Rowan-Szal, G.A., Joe, G.W., & Simpson, D.D. (1999). Gender differences at admission and follow-up in a sample of methadone maintenance clients. Substance Use and Misuse, 34(8), 1137-1165.
10. Criminal Justice Institute. 1993. Corrections Yearbook. Author, Middletown, CT.
11. Drummond, M.F., O’Brien, B.J., Stoddart, G.L., & Torrance, G.W., (1997). Methods for the economic evaluation of health care programmes (Second Edition). Oxford University Press, Oxford.
12. Etheridge, R.M., Hubbard R.L., Anderson, J., Craddock, S.G., & Flynn, P.M. (1997). Treatment structure and program services in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 244-260.
13. Flynn, P.M., Kristiansen, P.L., Porto, J.V., & Hubbard R.L. (1999). Costs and benefits of treatment for cocaine addiction in DATOS. Drug and Alcohol Dependence, 57(2), 167-174.
14. French, M.T. & Martin, R.F. (1996). The costs of drug abuse consequences: A Summary of research findings. Journal of Substance Abuse Treatment, 13(6), 453-466.
15. Gerstein, D.R., Johnson, R.A., Harwood, H.J., Fountain, D., Suter, N., & Malloy, K., (1994). Evaluating Recovery Services: The California Drug and Alcohol Treatment Assessment (CALDATA) General Report. California Department of Alcohol and Drug Programs, Sacramento, CA.
16. Gold, M.R., Siegel, J.E., Russell, L.B., & Weinstein, M.C. (Eds.), 1996. Cost-effectiveness in health and medicine. Oxford University Press, Oxford.
17. Hartz, D.T., Meek, P., Piotrowski, N.A., Tusel, D.J., Henke, C.J., Delucchi, K., Sees, K., & Hall, S.M. (1999). A cost-effectiveness and cost-benefit analysis of contingency contracting-enhanced methadone detoxification treatment. American Journal of Drug and Alcohol Abuse, 25(2), 207-218.
18. Harwood, H.J., Hubbard R.L., Collins, J.J., & Rachal, J.V., (1988). The costs of crime and the benefits of drug abuse treatment: A cost-benefit analysis using TOPS data. In Leukefield, C.G., Tims, F.M. (Eds.), Compulsory treatment of drug abuse: research and clinical Practice. NIDA Research Monograph 86. National Institute on Drug Abuse, Rockville, MD, pp. 209-235.
19. Hubbard R.L., Craddock, S.G., Flynn, P.M., Anderson, J., & Etheridge, R.M. (1997). Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 261-278.
20. Hubbard R.L., Marsden, M.E., Rachal, J.V., Harwood, H.J., Cavanaugh, E.R., & Ginzburg, H.M. (1989). Drug abuse treatment: a national study of effectiveness. Chapel Hill, NC: The University of North Carolina Press.
21. Koenig, L., Denmead, G., Nguyen, R., Harrison, M., & Harwood, H. (1999, May). The costs and benefits of substance abuse treatment: Findings from the National Treatment Improvement Evaluation Study (NTIES). Paper presented at the meeting of the National Evaluations Data Services (NEDS), Washington, DC.
22. Koenig, L., Denmead, G., Nguyen, R., Harrison, M., & Harwood, H. (1999). The costs and benefits of substance abuse treatment: Findings from the National Treatment Improvement Evaluation Study (NTIES). (National Evaluation Data Services Technical Report document published under Caliber/NEDS Contract No. 270-97-7016, Center for Substance Abuse Treatment, Department of Health and Human Services).
23. Magura, S., & Rosenblum, A. (2001). Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. Mt. Sinai Journal of Medicine, 68(1), 62-74.
24. Magura, S., Rosenblum, A., & Rodriguez, E.M. (1998). Changes in HIV-risk behaviors among cocaine-using methadone patients. Journal of Addictive Disease, 17(4), 71-90.
25. Maisto, S.A., Sobell, L.C., & Sobell, M.B. (1982). Corroboration of drug abusers’ self-reports through the use of multiple data sources. American Journal of Drug and Alcohol Abuse, 9, 301-308.
26. Metzger, D.S., Woody, G.E., McLellan, A.T., Druley, P., DePhillips, D., O’Brien, C., Stolley, P., & Abrutyn, E. (1993). HIV seroconversion among in and out of treatment intravenous drug users: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes, 6(9), 1049-1056.
27. National Opinion Research Center at the University of Chicago, (1997). The National Treatment Improvement Evaluation Study: Final Report. Center for Substance Abuse Treatment, Rockville, MD.
28. Rajkumar, A.S. & French, M.T. (1997). Drub abuse, crime costs, and the economic benefits of treatment. Journal of Quantitative Criminology, 13(3), 291-323.
29. Sells, S.B., Simpson, D.D., (1980). The case for drug abuse treatment effectiveness, based on the DARP research program. British Journal of the Addictions, 75, 117-131.
30. Simpson, D.D., (1981). Treatment for drug abuse: Follow-up outcomes and length of time spent. Archives of General Psychiatry, 38, 875-880.
31. Simpson, D.D., (1997). Effectiveness of drug abuse treatment: A review of research from field settings. In J.A. Egertson, D.M. Fox & A. I. Leshner (Eds.), Treating drug abusers effectively (pp. 41-73). Cambridge, MA: Blackwell.
32. Simpson, D.D. & Sells, S.B., (1982). Effectiveness of treatment for drug abuse: An overview of the DARP research program. Advances in Alcohol and Substance Abuse 2, 7-29.
33. Simpson, D.D. & Sells, S.B., (1990). Opioid addiction and treatment: A 12-year follow-up. Robert E. Krieger, Malabar, FL
34. Simpson, D.D., Joe, G.W., & Brown, B.S. (1997). Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 294-307.
35. Simpson, D.D., Joe, G.W., Fletcher, B.W., Hubbard R.L., & Anglin, M.D. (1999). A National evaluation of treatment outcomes for cocaine dependence. Archives of General Psychiatry, 56, 507-514.
36. Torrance, J.E., Siegel, J.E., & Luce, B.R. (1996). Framing and designing the cost-effectiveness analysis. In M.R. Gold, J.E. Siegel, L.B. Russell, & M. C. Weinstein (Eds.), Cost-effectiveness in health and medicine (pp. 54-81). Oxford University Press, NY.
37. U.S. Department of Health and Human Services, 1992. NDATUS Instruction Manual (DHHS Publication No. ADM 92-1932). Substance Abuse and Mental Health Services Administration., Rockville, MD.
38. Zanis, D.A. & Woody, G.E. (1998). One year mortality rates following methadone treatment discharge. (1998). Drug and Alcohol Dependence, 52, 257-260.